Published in J Thromb Haemost on October 01, 2008
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies. Europace (2013) 1.53
Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat Rev Nephrol (2012) 1.23
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics. BMC Health Serv Res (2013) 0.98
Factors affecting the quality of anticoagulation with warfarin: experience of one cardiac centre. Kardiochir Torakochirurgia Pol (2015) 0.95
Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scores. Am J Cardiovasc Dis (2012) 0.88
The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2011) 0.86
Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients. BMC Nephrol (2011) 0.83
Use of novel oral anticoagulant agents in atrial fibrillation: current evidence and future perspective. Cardiovasc Diagn Ther (2014) 0.81
Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study. BMC Res Notes (2014) 0.80
Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J (2009) 0.79
Oral anticoagulation should be managed in the community with treatment aimed at standard therapeutic targets and increased recall intervals. J Thromb Haemost (2008) 0.77
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. BMJ Open (2016) 0.77
Anticoagulation in pulmonary arterial hypertension: Contemporary data from COMPERA registry. Glob Cardiol Sci Pract (2014) 0.75
Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword. Res Cardiovasc Med (2013) 0.75
Atrial fibrillation in women: treatment. Nat Rev Cardiol (2016) 0.75
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation. Oncotarget (2016) 0.75
Quality of anticoagulation control among patients with atrial fibrillation: An experience of a tertiary care center in Saudi Arabia. J Saudi Heart Assoc (2016) 0.75
Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience. J Adv Pharm Technol Res (2017) 0.75
Using highly variable warfarin dosing to identify patients at risk for adverse events. Thromb J (2011) 0.75
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States. Int J Clin Pract (2016) 0.75
[Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation]. Herz (2010) 0.75
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost (2009) 1.68
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost (2010) 1.68
Volumetric and semiquantitative assessment of MRI-detected subchondral bone marrow lesions in knee osteoarthritis: a comparison of contrast-enhanced and non-enhanced imaging. Osteoarthritis Cartilage (2010) 1.08
Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol (1997) 1.08
Power to detect spatial disturbances under different levels of geographic aggregation. J Am Med Inform Assoc (2009) 1.06
An ecological approach to examine lung cancer disparities due to sexual orientation. Public Health (2012) 0.97
Superior semicircular canal dehiscence: congenital or acquired condition? AJNR Am J Neuroradiol (2011) 0.95
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost (2010) 0.94
IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J Immunol (1999) 0.92
Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy. AJNR Am J Neuroradiol (2011) 0.89
Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification. J Thromb Haemost (2011) 0.86
INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost (2012) 0.84
Warfarin dose management affects INR control. J Thromb Haemost (2008) 0.83
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial. J Thromb Haemost (2014) 0.82
Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost (2013) 0.81
Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics. JIMD Rep (2015) 0.80
Explanatory factors of sexual function in sexual minority women breast cancer survivors. Ann Oncol (2012) 0.80
Pathways to poor anticoagulation control. J Thromb Haemost (2014) 0.79
Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med (1995) 0.78
Quantitative MRI analysis of craniofacial bone marrow in patients with sickle cell disease. AJNR Am J Neuroradiol (2012) 0.77
Quantitative MRI analysis of salivary glands in sickle cell disease. Dentomaxillofac Radiol (2012) 0.76
How the doctor got gagged. JAMA (1992) 0.75
Anticoagulation for valvular heart disease in community-based practice. Thromb Haemost (2009) 0.75
Clinical significance of trochlear calcifications in the orbit. AJNR Am J Neuroradiol (2013) 0.75